
Fluorofenidone
CAS No. 848353-85-5
Fluorofenidone( AKF-PD )
Catalog No. M26688 CAS No. 848353-85-5
Fluorofenidone attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 53 | In Stock |
![]() ![]() |
5MG | 87 | In Stock |
![]() ![]() |
10MG | 147 | In Stock |
![]() ![]() |
25MG | 295 | In Stock |
![]() ![]() |
50MG | 514 | In Stock |
![]() ![]() |
100MG | 737 | In Stock |
![]() ![]() |
500MG | 1521 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameFluorofenidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionFluorofenidone attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway.
-
DescriptionFluorofenidone attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway. Fluorofenidone is an analogue of AMR69. Which displays equivalent lower toxicity, antifibrotic activity, and longer half-life.
-
In Vitro——
-
In Vivo——
-
SynonymsAKF-PD
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number848353-85-5
-
Formula Weight203.216
-
Molecular FormulaC12H10FNO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 140 mg/mL (688.94 mM)
-
SMILESCc1ccc(=O)n(c1)-c1cccc(F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shi J, et al. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation. Drug Metab Dispos. 2016 Apr;44(4):554-9.
molnova catalog



related products
-
Eldacimibe
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
-
3,5-Dihydroxy-4-meth...
3,5-Dihydroxy-4-methylbenzoic acid is a natural product.
-
NSC 247030
NSC 247030 is a biochemical.